PNPLA2 and Hepatic steatosis: Impairment of adipocyte lipolysis via adipocyte-specific ATGL deletion improves systemic glucose homeostasis and protects from hepatic steatosis by reducing fatty acid delivery to non-adipose tissues, and subsequently, lipotoxicity6–8.